MALLORY CROWNOVER: Open Payments
NPI 1700390721 · SPRINGFIELD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,360 in 58 payments from 19 companies in 2025. Trend: 2023 $901 · 2024 $579 · 2025 $1,360
Food & beverage: $1,344Education: $16
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $256 |
| AstraZeneca Pharmaceuticals LP | 5 | $172 |
| Lilly USA, LLC | 5 | $161 |
| Madrigal Pharmaceuticals | 4 | $160 |
| Novo Nordisk Inc | 6 | $117 |
| GlaxoSmithKline, LLC. | 5 | $113 |
| Corcept Therapeutics | 3 | $50 |
| Merck Sharp & Dohme LLC | 1 | $41 |
| Amgen Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $33 |
Products named: REZDIFFRA, BREZTRI, ELIQUIS, NURTEC ODT, TRELEGY ELLIPTA, Ozempic, Korlym, M-M-R II.
Industry payments across OR — which companies pay providers there.
